Manifold MarketsNo KYCVerified resolution dataFairly calibratedCurrent community forecastPortugal 94%Leader of 13 outcomes
Forecasters
17
Question type
multiple choice
Methodology
Play-money forecasting platform
Source type
Forecast
7d Change
0.0 pts
Market data
Updated 10 hours ago
StaleMar 27, 24, 7:24 PM UTCDec 31, 29, 10:59 PM UTC
Trends
Rules
This market resolves Yes to each country that legalizes the use of one or more psychedelic substances between market creation and market close, including cases in which such use is contingent on prescription by a licensed medical professional.
- At the time of market creation, studies on the efficacy of psychedelic substances in mental health treatments are being conducted by various institutes globally.
- Several countries have shown interest in exploring the therapeutic potential of psychedelics, with promising results emerging in the treatment of addiction, schizophrenia, depression, and other disorders.
- Some of the countries listed as options already allow the use of some psychedelics in some or all settings.
- For example, Australia has legalized the prescription of MDMA and psylocibin effective Jul 1, 2023.
- In Germany, ibogaine is legal while other psychedelics remain illegal.
